Crucell N.V.Leiden The Netherlands
Company Description
Crucell wants to play a crucial role in the fight against deadly diseases. The global biotech firm develops, produces, and markets vaccines and antibodies to prevent and treat infectious diseases. Many of its products are based on its PER.C6 technology platform, and its primary product lines are focused on pediatric, travel, endemic (native to certain regions), and respiratory ailments. Crucell's marketed vaccines fight about a dozen major infectious diseases (including diptheria, hepatitis A and B, influenza, and typhoid) and are offered in more than 100 countries worldwide. The company was acquired by
| Archimedesweg 4-6 | Phone: +31-71-519-91-01 | |
| Leiden 2333 CN | Fax: +31-71-519-98-00 | 
Map This Company |
| The Netherlands |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Crucell N.V. Rankings
Executives
| 18 executives listed for Crucell N.V.'s Leiden, The Netherlands location. | ||
| Chairman | Jan Oosterveld | |
|---|---|---|
| President and CEO | Ronald Brus | |
| COO | Cees de Jong | |
Financials
| Company Type | Subsidiary - NASDAQ: CRXL Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 1,300 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Crucell N.V. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
